21st Mar 2005 16:22
Allergy Therapeutics PLC21 March 2005 Schedule 10 NOTIFICATION OF MAJOR INTERSTS IN SHARES 1. Name of Company Allergy Therapeutics plc 2. Name of shareholder having a major interest Fidelity International Limited (FIL) and its direct and indirect subsidiaries 3. Please state whether notification indicates that it is inrespect of holding of the shareholder names in 2 above or in respect of anon-beneficial interest or in the case of children under the age of 18 Non-beneficial interest 4. Name of the registered holder(s) and, if more than oneholder, the number of share held by each of them Nominee/registered name Share held Management CompanyJP Morgan, Bournemouth 757,100 Fidelity Inv Services LtdBank of New York, Brussels 399,600 Fidelity Pension Mgmnt(FPM)Bankers Trust London 103,400 FPMCITIBANK London 128,400 FPMClydesdale Bank plc 42,300 FPMJP Morgan, Bournemouth 220,900 FPMMellon Bank 232,100 FPMMidland Securities Services 74,300 FPMNorthern Trust London 427,200 FPMState STR BK and TR Co London 161,700 FPM 5. Number of shares/amount of stock acquired 2,547,000 6. Percentage of issued class 4.05% 7. Number of shares/amount of stock disposed - 8. Percentage of issued class - 9. Class of security Ordinary shares 10. Date of transaction Not notified 11. Date company informed 18th March 2005 12. Total holding following this notification 2,547,000 13. Total percentage holding of issued class following thisnotification 4.05% 14. Any additional items Notifiable interest also comprises the intrest of Mr.Edward C. Johnson 3d Aprincipal Shareholder of Fidelity International Limited 15. Name of contact and telephone number for queries Ian Postlethwaite - 01903 844721 16. Name and signature of authorised company official responsiblefor make this notification Ian Postlethwaite Date of notification 21st March 2005 The FSA does not give any express or implied warranty as to the accuracy of thisdocument or material and does not accept liability for error or omission. TheFSA is not liable for any damages (including, without limitation, damages forloss of business or loss of profits) arising in contract, tort or otherwise fromthe use of or inability to use this document, or any material contained in it,or from any action or decision taken as a result of using this document or anysuch material. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Allergy Thera.